In tests using animals, drug successfully seeks and disarms toxic clumps of proteins responsible for Alzheimer’s and Parkinson’s
An international team of more than 18 research groups has demonstrated that the compounds they developed can safely prevent harmful protein aggregation in preliminary tests using animals. The findings raise hope that a new class of drugs may be on the horizon for the more than 30 diseases and conditions that involve protein aggregation, including diabetes, cancer, spinal cord injury, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
Proteins are necessary for almost every cellular process. However, when cell machinery doesn’t clear out old proteins, they can clump, or aggregate, into toxic plaques that lead to disease.
“Diseases caused by protein aggregation affect millions of people around the world,” said Gal Bitan, Ph.D., associate professor of neurology at the David Geffen School of Medicine at the University of California – Los Angeles, who will present the team’s latest work at the American Society for Biochemistry and Molecular Biology (ASBMB) Annual Meeting during Experimental Biology 2015. “We hope that the new compounds will provide therapy for diseases caused by protein aggregation, many of which have no treatment at all.”
The researchers call the compounds that they developed molecular tweezers because of the way they wrap around the lysine amino acid chains that make up most proteins. The compounds are unique in their ability to attack only aggregated proteins, leaving healthy proteins alone.
To develop a new drug, researchers typically screen large libraries of compounds to find ones that affect a protein involved in a disease. Bitan’s team used a fundamentally different approach to develop the molecular tweezers.
“We looked at the molecular and atomic interactions of proteins to understand what leads to their abnormal clumping,” Bitan said. “Then, we developed a tailored solution. So unlike many other drugs, we understand how and why our drug works.”
The team is in the process of testing multiple versions of the tweezers, each with a slightly different molecular makeup. For CLR01, one of the most promising versions, the researchers have demonstrated therapeutic benefits in two rodent models of Alzheimer’s disease, two fish and one mouse model of Parkinson’s disease, a fish model of spinal cord injury and a mouse model of familial amyloidotic polyneuropathy, a rare disease in which protein aggregation affects the nervous system, heart and kidneys.
“Our data suggest that CLR01, or a derivative thereof, may become a drug for a number of diseases that involve protein aggregation,” Bitan said. “We also found a high safety window for CLR01.”
In one of the safety tests, mice receiving a daily CLR01 dose 250 times higher than the therapeutic dose for one month showed no behavioral or physiological signs of distress or damage. In fact, blood cholesterol in the mice dropped by 40 percent, a possible positive side effect of CLR01.
Read more: New Compounds Could Offer Therapy for Multitude of Diseases
The Latest on: Molecular tweezers
[google_news title=”” keyword=”Molecular tweezers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Molecular tweezers
- Physicists create an optical tweezer array of individual polyatomic molecules for the first timeon May 3, 2024 at 8:49 am
The research team suggests their technique could be used with other three-atom molecules, opening up new avenues of polyatomic molecular research. More information: Nathaniel B. Vilas et al, An ...
- Physicists create an optical tweezer array of individual polyatomic molecules for the first timeon May 2, 2024 at 5:00 pm
opening up new avenues of polyatomic molecular research. More information: Nathaniel B. Vilas et al, An optical tweezer array of ultracold polyatomic molecules, Nature (2024). DOI: 10.1038 ...
- The Mysteries of Plant ‘Intelligence’on May 1, 2024 at 7:19 am
Scientists are debating whether concepts such as memory, consciousness, and communication can be applied beyond the animal kingdom.
- Molecular Biology Newson April 30, 2024 at 5:00 pm
May 9, 2024 — In a study of a species of African butterfly, researchers have discovered a previously undescribed molecular mechanism of how the sex of an embryo is initially ... Fruit Fly Model ...
- Individual polyatomic molecules are trapped in optical-tweezer arrayson April 23, 2024 at 5:00 pm
The central requirement is that the tweezer must not cause unintended excitation into ... “But you can think of each one as an independent molecular qubit, so our goal would be to start implementing ...
- Diamond-based quantum sensing microscope offers effective approach for quantifying cellular forceson April 21, 2024 at 5:00 pm
Currently, several leading technologies such as traction force microscopy (TFM), optical/magnetic tweezers, and molecular tension-based fluorescence microscopy (MTFM) are widely used for measuring ...
- Force Spectroscopy: Probing Molecular Interactions at the Nanoscaleon March 31, 2024 at 7:49 pm
Optical tweezers are particularly useful for studying the mechanical properties of biomolecules, such as DNA and proteins, and for measuring the forces generated by molecular motors. Magnetic tweezers ...
- Journal of the American Society for Mass Spectrometryon November 21, 2023 at 4:00 pm
Characterization of Molecular Tweezer Binding on α-Synuclein with Native Top-Down Mass Spectrometry and Ion Mobility-Mass Spectrometry Reveals a Mechanism for Aggregation Inhibition. An In Silico ...
- Biochemistry and Molecular Geneticson October 30, 2023 at 5:00 pm
Committed to exploring new frontiers in basic and translational research, the Department of Biochemistry and Molecular Genetics is an integral part of the vibrant biomedical research community at UAB.
- Molecular BioSystemson August 13, 2023 at 12:47 am
Molecular BioSystems has been renamed Molecular Omics. Molecular Omics publishes molecular level experimental and bioinformatics research in the -omics sciences, including genomics, proteomics, ...
via Bing News